Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
08/08/201614h50Dow Jones NewsAllergan Revenue Increases, Though Loss WidensNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201614h12Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201614h00Business WireTeva Announces Launch of Generic Gleevec® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201620h47Dow Jones NewsTeva Profit Falls on Write-DownsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201613h00Business WireTeva Reports Second Quarter 2016 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/08/201609h03Dow Jones NewsBusiness Watch -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201615h21Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201614h40Dow Jones NewsTeva to Buy Generics Distributor Anda From Allergan for $500 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201613h00Business WireTeva Announces Acquisition of Anda Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201609h03Dow Jones NewsIn Quest to Grow, Rivals Woo Biogen -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201601h59Dow Jones NewsBiogen Draws Takeover Interest from Rival Drugmakers--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h30Dow Jones NewsBiogen Attracts Takeover Interest From Two RivalsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h22Dow Jones NewsBiogen Draws Takeover Interest from Rival Drugmakers--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h12Dow Jones NewsBiogen Draws Takeover Interest from Rival DrugmakersNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201620h06PR Newswire (US)Teva Completes Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201617h10Business WireCORRECTING & REPLACING Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection...NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/201615h00Business WireTeva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500mg/2 mL (250 mg...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201615h42Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201609h03Dow Jones NewsFacebook Rides Mobile-Ad Surge -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201602h00Dow Jones NewsFacebook Posts Strong Profit and Revenue Growth--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201601h41Dow Jones NewsCorrection to Teva, Allergan ArticleNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201622h50Dow Jones NewsFacebook Posts Strong Profit and Revenue GrowthNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201622h01Business WireTeva to Report Second Quarter 2016 Financial Results on August 4, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201622h00Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201620h36Business WireTeva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics AcquisitionNYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/201620h52Business WireTeva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
20/07/201622h03Business WireTeva Announces Pricing of Additional €4.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201623h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201612h05Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201603h17Business WireTeva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA